Feb 22, 2018 - Acadia has one product to market and their pipeline solely consists of other indications for that product. It is difficult to justify the current Acadia valuation based on Parkison's Disease psychosis
Feb 20, 2018 - ACADIA (ACAD) is expected to provide further update on the progress of Nuplazid when it reports Q4 results on Feb 27.
Jan 29, 2018 - 5 Health Care Stocks in Gurus' Portfolios, Stocks: EXEL,CELG,INCY,PTLA,ACAD, David Rolfe,Ken Fisher, release date:Jan 29, 2018
Jan 19, 2018 - Rhenman & Partners Asset Management AB Buys ACADIA Pharmaceuticals Inc, Gilead Sciences Inc, Sage Therapeutics Inc, Sells Horizon Pharma PLC, Nektar Therapeutics Inc, Nevro Corp, Stocks: GILD,SAGE,ABC,JAZZ,ESPR,AGIO,ACAD,FLXN,PBYI,SGMO,O, release date:Jan 19, 2018
Jan 10, 2018 - The following slide deck was published by ACADIA Pharmaceuticals Inc. in conjunction with this event.
Jan 10, 2018 - Acadia CEO Stephen Davis outlines the path to success for the biotech at the J.P. Morgan Healthcare Conference.
Jan 08, 2018 - ACADIA is climbing back slowly after last November's sell-off. NUPLAZID revenue growth may beat market expectations. Strong sales team performance could add to prescription growth this quarter.
Jan 06, 2018 - Acadia had a disappointing 2017.Nuplazid sales in 2017 were strong.Much of the value still unlocked.
Dec 29, 2017 - TherapeuticsMD (TXMD) announces submission of NDA to the FDA seeking approval of TX-001HR to treat vasomotor symptoms in post-menopausal women.
Dec 28, 2017 - The Zacks Analyst Blog Highlights: ACADIA Pharmaceuticals, Sangamo Therapeutics, AnaptysBio and Sino Biopharmaceutical